ADHD is one of the most common neurodevelopmental differences in kids; about 1 in 10 U.S. children are diagnosed. Signs often show up early, even before kindergarten. A recent national survey found 2.4% of children ages 3–5 had already received an ADHD diagnosis.
Why does this matter? Because preschool years lay the foundation. Early struggles with focus or emotional regulation can affect learning, friendships, and self-esteem. That’s why pediatricians — especially primary care providers (PCPs) — are urged to catch ADHD early and respond thoughtfully.
The American Academy of Pediatrics recommends starting with behavioral strategies, such as parent training. These work better than medication for young children. Stimulant meds, like methylphenidate, should only be used if behavioral tools don’t help.
In practice, most children are first diagnosed and treated for ADHD by their PCPs. Until now, though, very few studies have looked at how treatment actually unfolds in preschoolers , especially the timing of medication. Past research mostly used surveys or insurance claims.
This study helps fill that gap. It analyzed real-world data from 8 major pediatric health systems to understand:
- How often are kids aged 3–5 diagnosed with ADHD
- How soon are medications prescribed
- Whether age, race, gender, or insurance influences that timing
Methods
How the study worked:
Researchers used electronic health records from eight U.S. children’s hospitals in the PEDSnet research network (2016–2023). They included kids aged 3–5 with at least two PCP visits and six months of follow-up.
To capture true primary care, they filtered for well-child visits and vaccines, excluding labs and specialty visits.
ADHD can show up in records as either symptom-level (inattention, hyperactivity) or disorder-level (formal ADHD diagnosis). For this study, only kids who got a disorder-level diagnosis between ages 4–5 were included. Researchers then tracked whether they were prescribed ADHD meds up to age 7.
They also noted co-occurring conditions (like autism, anxiety, sleep problems, or disruptive behaviors) that might affect treatment decisions.
Results
Out of 712,000+ kids aged 3–5, about 9,700 (1.4%) were diagnosed with ADHD at ages 4–5. Most were boys (76%)—racial breakdown: 39% White, 31% Black, 18% Hispanic, 1% Asian.
Key findings:
- 68.2% were prescribed ADHD meds by age 7
- 42.2% got their first prescription within 30 days — despite guidelines recommending behavior therapy first
Treatment timing varied by group:
- White kids were more likely to get meds quickly
- Asian, Black, and Hispanic kids were less likely to be treated early
- Older kids, boys, and those with public insurance were more likely to get early prescriptions
- Kids with sleep problems or disruptive behaviors also started meds sooner
- Kids with autism or developmental delays were less likely to be prescribed meds early
Only about 40% had a follow-up visit within 2 months of starting medication.
Timing of Medication
Think of this as a timeline after diagnosis:
- 42% started meds within 30 days
- 14% waited more than 6 months
- Kids diagnosed at age five often got meds immediately (median time: 0 days)
By race and ethnicity:
- White & Multiracial kids: 44–48% treated early
- Black kids: 42%
- Hispanic kids: 36%
- Asian kids: 29%
Two years later, 78% of White kids had received meds, compared with only 56% of Asian kids.
Regression Analysis
When researchers controlled for other factors:
- Asian kids were 49% less likely than White kids to get meds early
- Hispanic kids: 25% less likely
- Black kids: 12% less likely
- Older age, male gender, and public insurance increased odds of early treatment
- Sleep issues and disruptive behaviors led to quicker medication use
- Autism or developmental delays made early prescriptions less likely
Sensitivity Analyses
Researchers tested results in different ways:
- When they counted nonspecific behavior concerns (like “behavior problem”), time to meds was slower overall
- Kids first diagnosed at the symptom level (not full ADHD) got meds later — showing PCPs are more cautious without a formal diagnosis
🧠 Discussion
Key takeaways:
- There’s wide variation in how preschool ADHD is treated across U.S. health systems
- Nearly half are prescribed meds quickly — sometimes before behavioral supports are tried
- Race and insurance matter — White kids and kids with public insurance are more likely to get meds early
- For families with public insurance, early meds may reflect barriers to behavior therapy (like limited access to parent training)
- High rates of early medication in White kids highlight systemic and cultural differences in treatment pathways
🧠 Limitations
The study had limits:
- Relied on diagnosis codes — may miss clinical details
- Some kids may have started treatment before an official diagnosis
- Didn’t capture provider notes — so behavioral therapy may have been recommended but not documented
- Some meds could’ve been prescribed for other issues, like sleep problems
💡 Final Takeaways
- Preschool ADHD is diagnosed, but not equitably. Identity and insurance shape who gets care and when
- Behavioral supports are often skipped. Nearly half of kids got meds within a month of diagnosis
- System barriers matter. Families with public insurance often face limited access to behavioral therapies
- Racial disparities persist. Asian, Black, and Hispanic children are less likely to get early treatment
- Families and clinicians need support. Access to behavioral care, clearer diagnosis processes, and culturally affirming approaches are essential